NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO)

CUSIP: 66737P600

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
6,219,683
Share change
+762
Total reported value
$23,446,147
Put/Call ratio
245%
Price per share
$3.77
Number of holders
39
Value change
+$3,227
Number of buys
1
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 66737P600?
CUSIP 66737P600 identifies NWBO - NORTHWEST BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) as of Q4 2013

As of 31 Dec 2013, NORTHWEST BIOTHERAPEUTICS INC - COM (NWBO) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,219,683 shares. The largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, Whitebox Advisors LLC, ROYAL BANK OF CANADA, CREDIT SUISSE AG/, Allianz Asset Management AG, Majedie Asset Management Ltd, Bedell Investment Counselling, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.